1. Home
  2. STOK vs HMN Comparison

STOK vs HMN Comparison

Compare STOK & HMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$24.97

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Horace Mann Educators Corporation

HMN

Horace Mann Educators Corporation

HOLD

Current Price

$46.21

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
STOK
HMN
Founded
2014
1945
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
STOK
HMN
Price
$24.97
$46.21
Analyst Decision
Strong Buy
Buy
Analyst Count
14
3
Target Price
$46.46
★ $56.50
AVG Volume (30 Days)
★ 782.2K
253.6K
Earning Date
10-29-2026
11-03-2026
Dividend Yield
N/A
★ 3.04%
EPS Growth
★ 92.73
57.26
EPS
N/A
★ 2.01
Revenue
$184,420,000.00
★ $1,701,400,000.00
Revenue This Year
N/A
$3.85
Revenue Next Year
$39.98
$17.18
P/E Ratio
★ N/A
$23.54
Revenue Growth
★ 404.50
6.66
52 Week Low
$20.32
$41.29
52 Week High
$40.22
$55.56

Technical Indicators

Market Signals
Indicator
STOK
HMN
Relative Strength Index (RSI) 45.36 46.32
Support Level $24.21 $41.72
Resistance Level $33.61 $46.75
Average True Range (ATR) 1.33 0.86
MACD 0.35 0.31
Stochastic Oscillator 56.19 51.92

Price Performance

Historical Comparison
STOK
HMN

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About HMN Horace Mann Educators Corporation

Horace Mann Educators Corp is a diversified insurance holding company that markets and underwrites personal lines of property and casualty insurance, retirement annuities, and life insurance. The company's property and casualty operations focus on automobile and homeowner insurance, while the retirement annuities are tax-qualified products. Horace Mann Educators markets its products to kindergarten through 12th-grade teachers, administrators, and other employees of public schools and their families. The Company conducts and manages its business in four reporting segments: (1) Property & Casualty, (2) Life & Retirement, (3) Supplemental & Group Benefits and (4) Corporate & Other.

Share on Social Networks: